个人简历

刘洪卓，女，博士，教授。2002年毕业于沈阳药科大学，获药学学士学位，2007年于同校获药物制剂博士学位，毕业后赴美国UniversityofCincinnati进行博士后研究。作为课题负责人主持了国家自然科学基金青年、面上基金项目各1项，辽宁省高等学校杰出青年学者成长计划1项，另外，作为项目骨干成员承担国家自然科学基金面上项目3项。目前已有论文40余篇。

研究领域

""现主要从事新型疫苗及佐剂的开发，借助智能材料和纳米技术实现对免疫系统的调控，从而探索新型疫苗及疗法。""""

近期论文

1.ShanshanHou,YangYang,ShuangZhou,XiaoKuang,YinXianYang,HailingGao,ZhenjieWang,HongzhuoLiu，NovelSS-31modifiedliposomesforimprovedprotectiveefficacyofminocyclineagainstdrug-inducedhearingloss，BiomaterSci，2018，6:1627-35.(IF5.831)\r
2.ZhenjieWang,XiaoKuang,JiaShi,WeilingGuoandHongzhuoLiu,Targeteddeliveryofgeranylgeranylacetonetomitochondriabytriphenylphosphoniummodifiednanoparticles:apromisingstrategytopreventaminoglycoside-inducedhearingloss,BiomaterSci,2017,5(9):1800-1809.（IF5.831）\r
3.ZhenjieWang,WeilingGuo,XiaoKuang,ShanshanHou,HongzhuoLiu,Nanopreparationsformitochondriatargetingdrugdeliverysystem:Currentstrategiesandfutureprospective,AsianJPharmSci,2017,12(6):498–508(IF4.56)\r
4.MengjuanJiang,RuoshiZhang,YingliWang,WennaJing,YingLiu,YanMa,BingjunSun,MenglinWang,PeizhuoChen,HongzhuoLiu,andZhongguiHe,Reduction-sensitivepaclitaxelprodrugself-assemblednanoparticleswithtetrandrineeffectivelypromotesynergistictherapyagainstdrug-sensitiveandmultidrug-resistantbreastcancer,MolPharm.2017,14:3628-3635(IF4.556)\r
5.HuangZH,LiHR,ZhangQ,LuFZ,HongM,ZhangZG,GuoXC,ZhuYJ,LiSM,LiuHZ,Discoveryofindolinone-basedmultikinaseinhibitorsaspotentialtherapeuticsforidiopathicpulmonaryfibrosis,ACSMedChemLett.2017,8:1142-1147(IF3.794)\r
6.CheXin,WangLihong,LiQiuyuan,LiuHongzhuo,Injectablelong-termcontrol-releasedinsitugelsofhydrochloricthiothixeneforthetreatmentofschizophrenia:Preparation,invitroandinvivopreparation.IntJPharm,2014,469(1):23-30.（IF3.65）\r
7.ShuangZhou,YanhuiSun,XiaoKuang,ShanshanHou,YinXianYang,ZhenjieWang,HongzhuoLiu,Mitochondria-targetingnanomedicine:Aneffectiveandpotentstrategyagainstaminoglycosides-inducedototoxicity,EurJPharmSci,2018,126:59-68(IF=3.466)\r
8.XinChe,ZhenjieWang,YiningLiu,YanhuiSun,HongzhuoLiu,Sustainedreleaseofnervegrowthfactorfromhighlyhomogenouscubosomesstabilizedbyβ-caseinwithenhancedbioactivityandbioavailability,RSCAdvances,2016,6,114676-114684.（IF3.108）\r
9.TaoZhang,RuyiYang,ShengnanYang,JibinGuan,DongZhang,YanMa,HongzhuoLiu,Researchprogressofself-assemblednanogelandhybridhydrogelsystemsbasedonpullulanderivatives,DrugDeliv,2018,25:278-292(IF3.095)\r
10.XiaoKuang,ShuangZhou,WeilingGuo,ZhenjieWang,YanhuiSun&HongzhuoLiu,SS-31peptideenablesmitochondrialtargetingdrugdelivery:apromisingtherapeuticalterationtopreventhaircelldamagefromaminoglycosides,DrugDeliv,2017,24:1750-61(IF3.095)
1.辽宁省百千万人才工程千人层次；2.《沈阳药科大学学报》编委；3.《AsianJournalofPharmaceuticalSciences》助理编辑